Chaitan Khosla is a professor in the departments of Chemistry and Chemical Engineering at Stanford University. He is also the founding director of Stanford’s Innovative Medicines Accelerator (a partnership between Stanford Medicine and Sarafan ChEM-H). Chaitan received his PhD in 1990 at Caltech. After completing postdoctoral studies in genetics at the John Innes Centre in the UK, he joined Stanford University in 1992. His work on antibiotic biosynthetic mechanisms led to new methods for engineering enzyme assembly lines to make novel anti-infective agents. He and his collaborators have also studied the chemical biology of celiac disease, a widespread but overlooked autoimmune disorder. He has co-authored over 400 peer-reviewed publications and 75 issued U.S. patents. He is an elected member of the American Academy for Arts and Science, the U.S. National Academy of Engineering, and the U.S. National Academy of Sciences. Over the past three decades, he has helped launch four companies based on research advances in his laboratory.